Can Ficioglu MD, PhD
Dr. Ficicioglu is director of the Newborn Metabolic Screening Program and Lysosomal Storage Disease Center at The Children's Hospital of Philadelphia with expertise in newborn metabolic screening, lysosomal storage disorders, intermediary metabolism defects, galactosemia, and PKU. His research focuses on developing best practices in diagnostic algorithms and outcomes of inborn errors of metabolism detected through newborn screening.
He is also interested in clinical trials of new drugs to treat inborn errors of metabolism such as lysosomal storage disorders and phenylketonuria for which he has received several grants to support his clinical research. Currently, He has three service grants from Pennsylvania, Delaware, and New Jersey states’ newborn screening programs, and two clinical trials, and nine registries supported by pharmaceutical grants. His research has resulted in over 65 peer-reviewed journal articles as well as significant contributions to scientific committees, with emphasis on newborn screening and inborn errors of metabolism.
Dr. Can (John) Ficicioglu is currently an Associate Professor of Pediatrics at the Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania. He received his M.D. in 1985 from the University of Istanbul, Cerrahpasa Medical School. He completed his internship and residency in Pediatrics in 1991. He then went on to receive his Ph.D. in Histology and Embryology (1992-1996) from the University of Marmara, Istanbul. He advanced from Instructor (1992) to Associate Professor in Pediatrics (1996) in the Division of Metabolism/Nutrition at the Cerrahpasa Medical School, University of Istanbul. In 2000, He completed his Genetics fellowship at the Children’s Hospital Boston, Harvard Medical School.